239 related articles for article (PubMed ID: 19850104)
21. Expression of receptors for complement anaphylatoxins C3a and C5a following permanent focal cerebral ischemia in the mouse.
Van Beek J; Bernaudin M; Petit E; Gasque P; Nouvelot A; MacKenzie ET; Fontaine M
Exp Neurol; 2000 Jan; 161(1):373-82. PubMed ID: 10683302
[TBL] [Abstract][Full Text] [Related]
22. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy.
Drouin SM; Corry DB; Hollman TJ; Kildsgaard J; Wetsel RA
J Immunol; 2002 Nov; 169(10):5926-33. PubMed ID: 12421977
[TBL] [Abstract][Full Text] [Related]
23. Complement anaphylatoxin receptors C3aR and C5aR are required in the pathogenesis of experimental autoimmune uveitis.
Zhang L; Bell BA; Yu M; Chan CC; Peachey NS; Fung J; Zhang X; Caspi RR; Lin F
J Leukoc Biol; 2016 Mar; 99(3):447-54. PubMed ID: 26394814
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of anaphylatoxin C5a receptor expression during experimental allergic encephalomyelitis.
Nataf S; Davoust N; Barnum SR
J Neuroimmunol; 1998 Nov; 91(1-2):147-55. PubMed ID: 9846831
[TBL] [Abstract][Full Text] [Related]
25. Distinct roles of the anaphylatoxin receptors C3aR, C5aR1 and C5aR2 in experimental meningococcal infections.
Muenstermann M; Strobel L; Klos A; Wetsel RA; Woodruff TM; Köhl J; Johswich KO
Virulence; 2019 Dec; 10(1):677-694. PubMed ID: 31274379
[TBL] [Abstract][Full Text] [Related]
26. Deletion of both ICAM-1 and C3 enhances severity of experimental autoimmune encephalomyelitis compared to C3-deficient mice.
Smith SS; Ludwig M; Wohler JE; Bullard DC; Szalai AJ; Barnum SR
Neurosci Lett; 2008 Sep; 442(2):158-60. PubMed ID: 18634851
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation.
Baelder R; Fuchs B; Bautsch W; Zwirner J; Köhl J; Hoymann HG; Glaab T; Erpenbeck V; Krug N; Braun A
J Immunol; 2005 Jan; 174(2):783-9. PubMed ID: 15634899
[TBL] [Abstract][Full Text] [Related]
28. C3a and C5a promote renal ischemia-reperfusion injury.
Peng Q; Li K; Smyth LA; Xing G; Wang N; Meader L; Lu B; Sacks SH; Zhou W
J Am Soc Nephrol; 2012 Sep; 23(9):1474-85. PubMed ID: 22797180
[TBL] [Abstract][Full Text] [Related]
29. The C3a/C3aR axis mediates anti-inflammatory activity and protects against uropathogenic E coli-induced kidney injury in mice.
Wu KY; Zhang T; Zhao GX; Ma N; Zhao SJ; Wang N; Wang JX; Li ZF; Zhou W; Li K
Kidney Int; 2019 Sep; 96(3):612-627. PubMed ID: 31133456
[TBL] [Abstract][Full Text] [Related]
30. Chimeric receptors of the human C3a receptor and C5a receptor (CD88).
Crass T; Ames RS; Sarau HM; Tornetta MA; Foley JJ; Köhl J; Klos A; Bautsch W
J Biol Chem; 1999 Mar; 274(13):8367-70. PubMed ID: 10085065
[TBL] [Abstract][Full Text] [Related]
31. C3a expressed in the central nervous system protects against LPS-induced shock.
Boos L; Szalai AJ; Barnum SR
Neurosci Lett; 2005 Oct; 387(2):68-71. PubMed ID: 16085360
[TBL] [Abstract][Full Text] [Related]
32. Characterization of C3a and C5a receptors in rat cerebellar granule neurons during maturation. Neuroprotective effect of C5a against apoptotic cell death.
Bénard M; Gonzalez BJ; Schouft MT; Falluel-Morel A; Vaudry D; Chan P; Vaudry H; Fontaine M
J Biol Chem; 2004 Oct; 279(42):43487-96. PubMed ID: 15292245
[TBL] [Abstract][Full Text] [Related]
33. Increased Complement 3a Receptor is Associated with Behcet's disease and Vogt-Koyanagi-Harada disease.
Wang C; Cao S; Zhang D; Li H; Kijlstra A; Yang P
Sci Rep; 2017 Nov; 7(1):15579. PubMed ID: 29138505
[TBL] [Abstract][Full Text] [Related]
34. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
35. The complement anaphylatoxin C3a receptor (C3aR) contributes to the inflammatory response in dextran sulfate sodium (DSS)-induced colitis in mice.
Wende E; Laudeley R; Bleich A; Bleich E; Wetsel RA; Glage S; Klos A
PLoS One; 2013; 8(4):e62257. PubMed ID: 23638016
[TBL] [Abstract][Full Text] [Related]
36. Exacerbation of experimental autoimmune encephalomyelitis in ceramide synthase 6 knockout mice is associated with enhanced activation/migration of neutrophils.
Eberle M; Ebel P; Mayer CA; Barthelmes J; Tafferner N; Ferreiros N; Ulshöfer T; Henke M; Foerch C; de Bazo AM; Grösch S; Geisslinger G; Willecke K; Schiffmann S
Immunol Cell Biol; 2015 Oct; 93(9):825-36. PubMed ID: 25833068
[TBL] [Abstract][Full Text] [Related]
37. Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection.
Vieyra M; Leisman S; Raedler H; Kwan WH; Yang M; Strainic MG; Medof ME; Heeger PS
Am J Pathol; 2011 Aug; 179(2):766-74. PubMed ID: 21704012
[TBL] [Abstract][Full Text] [Related]
38. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
[TBL] [Abstract][Full Text] [Related]
39. Temporal overexpression of IL-22 and Reg3γ differentially impacts the severity of experimental autoimmune encephalomyelitis.
Eken A; Erdem S; Haliloglu Y; Zehra Okus F; Cakir M; Fatih Yetkin M; Akcakoyunlu M; Karayigit MO; Azizoglu ZB; Bicer A; Gur TN; Aslan K; Hora M; Oukka M; Altuntas HD; Ufuk Nalbantoglu O; Gundogdu A; Mirza M; Canatan H
Immunology; 2021 Sep; 164(1):73-89. PubMed ID: 33876425
[TBL] [Abstract][Full Text] [Related]
40. The receptor for the complement C3a anaphylatoxin (C3aR) provides host protection against Listeria monocytogenes-induced apoptosis.
Mueller-Ortiz SL; Morales JE; Wetsel RA
J Immunol; 2014 Aug; 193(3):1278-89. PubMed ID: 24981453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]